Life Sciences
The hub expands the company's research and development footprint in the region and hastens the development of AI-powered digital health technologies.
They will collaborate on identifying novel therapeutic drug candidates for lung cancer.
The partnership will give AeroFlow customers access to DME prescriptions.
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
The collaboration aims to foster innovation, commercialization and adoption of AI in imaging.
HCA members will have access to and support for MGI's single cell and spatial omics technologies.
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The aim of the alliance is to collect insights on patient outcomes and drug effectiveness with the Dario Connect platform.
The funding will support clinical trials for the company's NeuroHawk brain-scanning device.